Trial · NCT02299414
Adverse events210
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 210
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Asthma | Respiratory, thoracic and mediastinal disorders | Anti-hypertensive Therapy to Goal <140/90 mmHg | 3 | 1,208 | 3 |
| serious | Asthma | Respiratory, thoracic and mediastinal disorders | No Anti-hypertensive Unless BP is Severe (≥160/105 mmHg | 0 | 1,200 | 0 |
| serious | Anaemia | Blood and lymphatic system disorders | Anti-hypertensive Therapy to Goal <140/90 mmHg | 0 | 1,208 | 0 |
| serious | Anaemia | Blood and lymphatic system disorders | No Anti-hypertensive Unless BP is Severe (≥160/105 mmHg | 1 | 1,200 | 1 |
| serious | Disseminated intravascular coagulation | Blood and lymphatic system disorders | Anti-hypertensive Therapy to Goal <140/90 mmHg | 1 | 1,208 | 1 |
| serious | Disseminated intravascular coagulation | Blood and lymphatic system disorders | No Anti-hypertensive Unless BP is Severe (≥160/105 mmHg | 1 | 1,200 | 1 |
| serious | Foetal anaemia | Blood and lymphatic system disorders | Anti-hypertensive Therapy to Goal <140/90 mmHg | 1 | 1,208 | 1 |
| serious | Foetal anaemia | Blood and lymphatic system disorders | No Anti-hypertensive Unless BP is Severe (≥160/105 mmHg | 0 | 1,200 | 0 |
| serious | Foetal Death | Pregnancy, puerperium and perinatal conditions | Anti-hypertensive Therapy to Goal <140/90 mmHg | 36 | 1,208 | 36 |
| serious | Foetal Death | Pregnancy, puerperium and perinatal conditions | No Anti-hypertensive Unless BP is Severe (≥160/105 mmHg | 42 | 1,200 | 42 |
| serious | Foetal Growth Restriction | Pregnancy, puerperium and perinatal conditions | Anti-hypertensive Therapy to Goal <140/90 mmHg | 3 | 1,208 | 3 |
| serious | Foetal Growth Restriction | Pregnancy, puerperium and perinatal conditions | No Anti-hypertensive Unless BP is Severe (≥160/105 mmHg | 0 | 1,200 | 0 |
| serious | Preeclampsia | Pregnancy, puerperium and perinatal conditions | Anti-hypertensive Therapy to Goal <140/90 mmHg | 10 | 1,208 | 10 |
| serious | Preeclampsia | Pregnancy, puerperium and perinatal conditions | No Anti-hypertensive Unless BP is Severe (≥160/105 mmHg | 24 | 1,200 | 24 |
| serious | Death Neonatal | General disorders | Anti-hypertensive Therapy to Goal <140/90 mmHg | 5 | 1,208 | 5 |
| serious | Death Neonatal | General disorders | No Anti-hypertensive Unless BP is Severe (≥160/105 mmHg | 8 | 1,200 | 8 |
| serious | Stillbirth | Pregnancy, puerperium and perinatal conditions | Anti-hypertensive Therapy to Goal <140/90 mmHg | 13 | 1,208 | 13 |
| serious | Stillbirth | Pregnancy, puerperium and perinatal conditions | No Anti-hypertensive Unless BP is Severe (≥160/105 mmHg | 19 | 1,200 | 19 |
| serious | Maternal Death | General disorders | Anti-hypertensive Therapy to Goal <140/90 mmHg | 1 | 1,208 | 1 |
| serious | Maternal Death | General disorders | No Anti-hypertensive Unless BP is Severe (≥160/105 mmHg | 2 | 1,200 | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02299414/events